Cancer

Cancer is not just one disease, but a large group of almost one hundred diseases. Its two main characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate from the original site and spread to distant sites. If the spread is not controlled, cancer can result in death.

Cancer articles

Breast cancer funding restored by Komen Foundation to Planned Parenthood
The Susan G. Komen for the Cure Foundation reversed its decision and continues to fund breast cancer screenings at Planned Parenthood health centers. The outpouring of support online for Planned Parenthood and women in need of breast cancer screenings has been nothing short of astonishing, and because of it, the Planned Parenthood Breast Health Fund has received more than $3 million from thousands of people across the country in only three days.

Susan G. Komen stops funding breast cancer programs at Planned Parenthood
Planned Parenthood Federation of America expressed deep disappointment in response to the Susan G. Komen for the Cure Foundation's decision to stop funding breast cancer prevention, screenings and education at Planned Parenthood health centers.

Additional breast surgery common after partial mastectomy
Nearly one in four women who undergo a partial mastectomy for treatment of breast cancer have another surgery to remove additional tissue (reexcision), and there is substantial surgeon and institutional variation in the rate of reexcisions that cannot be explained by patients' clinical characteristics.

Erivedge approved for skin cancer metastatic basal cell carcinoma
Erivedge or vismodegib was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The Erivedge drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic).

New lung cancer test could accurately guide treatment for people with lung cancer
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.

Regorafenib improves survival of colorectal cancer patients
Regorafenib - an investigational drug - slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer. This is the first novel agent in eight years to show improvement in overall survival of colon cancer patients who have run out of treatment options.

Parabens in underarm products may lead to breast cancer in women
New research into the potential link between parabens and breast cancer has found traces of the chemicals in breast tissue samples from all of the women in the study. Parabens are commonly used as preservatives in cosmetics, food products and pharmaceuticals.

Red wine drinking may reduce breast cancer risk in women
A glass of red wine with dinner may reduce breast cancer risk in women. Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.

HPV DNA testing for all women aged 29 years and above
Implementation of HPV DNA testing in cervical screening leads to earlier detection of clinically relevant CIN grade 2 or worse, which when adequately treated, improves protection against CIN grade 3 or worse and cervical cancer. Early detection of high-grade cervical legions caused by HPV16 was a major component of this benefit.

Cancer screening guideline process revised by American Cancer Society
The American Cancer Society has revised its guideline formation process to achieve greater transparency, consistency, and rigor in creating guidance about cancer screening. The new methods align with new principles from the Institutes of Medicine (IOM).

Cancer screening in older adults appears common, US
A high percentage of adults age 75 years and older continue to report receiving cancer screenings, despite U.S. Preventive Services Task Force guidelines recommending against routine screening for breast, cervical, colorectal and prostate cancer for patients age 75 years and older.

Breast cancer vaccine reduces tumours in mice
Researchers have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases-including those that are resistant to common treatments.

Breast cancer survivors may experience mental abilities problems
Breast cancer survivors may experience problems with certain mental abilities several years after breast cancer treatment, regardless of whether they were treated with breast cancer chemotherapy plus radiation or radiation for breast cancer only.

HER growth proteins do not predict outcome of herceptin treatment breast cancer patients
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2 Positive Breast Cancer with Herceptin, say Mayo Clinic researchers.

New cancer drug development institute at UT MD Anderson
Academic and government leaders announced the establishment of a major new research institute at The University of Texas MD Anderson Cancer Center that will blend the best attributes of academic and industrial research to identify and validate new cancer targets, convert such scientific knowledge into new cancer drugs, and advance these novel agents into innovative clinical trials.

Avastin bevacizumab approval revoked to treat breast cancer in US
US health agency FDA Commissioner Margaret A. Hamburg, M.D. has revoked the approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.

High fiber diet reduces colorectal cancer risk
Eating a diet high in fibre, particularly from cereal and whole grains, is associated with a reduced risk of colorectal cancer. Intake of dietary fibre and whole grains is known to help protect against cardiovascular disease, but its association with colorectal cancer risk is less clear. And, although the idea that dietary fibre reduces the risk of colorectal cancer has been around for nearly 40 years.

35 new drugs approved in 2011 in US
Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines for patients, like two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin's lymphoma in 30 years; and the first new drug for lupus in 50 years.

Alcohol increases breast cancer risk in women
Women who consume alcohol show an increase in their risk of developing breast cancer. This relation is stronger for women who drink in binges, are also taking post-menopausal hormonal therapy, and/or have low intakes of dietary folate.

PSA test helps predicting biopsy need and low risk prostate cancer
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, California, US.

Breast cancer risk increases with high hormone levels
Eight different sex and growth hormones may rise the risk of breast cancer, each elevated hormone level increase risk by 16% in post-menopausal women.

7% breast cancer patients have breast reconstruction surgery
Breast reconstruction surgery has a very positive effort on women with breast cancer as they go through their breast cancer journey. Only 7% of female breast cancer patients opt for breast reconstruction surgery.

Bollywood actress Juhi Chawla to build hospital for needy children
Recently Bollywood actress Juhi Chawla revealed that she would build a hospital only for children. A hospital that combines homoeopathy and ayurveda with allopathy.

Tanning bed ban for minors under 18 in California US
California Governor Edmund G. Brown, Jr., signed groundbreaking legislation today that will prohibit the use of commercial indoor tanning devices for those under the age of 18. California is the first state to ban minors from using commercial tanning booths.

More aggressive treatment not necessary for men with a family history of prostate cancer
Approximately 10-20 percent of prostate cancer patients have a family history of the disease. There are three major factors that are used to evaluate the extent and aggressiveness of prostate cancer, help make treatment decisions, and estimate prognosis: the Prostate Specific Antigen Level (PSA), Gleason score (GS) from the biopsy, and the digital rectal exam findings (DRE).

Fair skin people may need vitamin D supplements
Researchers at the University of Leeds, funded by Cancer Research UK, suggest that people with very pale skin may be unable to spend enough time in the sun to make the amount of vitamin D the body needs - while also avoiding sunburn.

Cervical cancer virus HPV linked to oral cancer rise
A new study of oropharyngeal cancer suggests that dramatic increases in U.S. incidence of the cancer and survival since 1984 can be attributed to infection with the human papillomavirus (HPV).

Alarm clock gene responsible for wake up every morning
Ever wondered why you wake up in the morning - even when the alarm clock isn't making jarring noises? Wonder no more. Researchers at the Salk Institute for Biological Studies have identified a new component of the biological clock, a gene responsible for starting the clock from its restful state every morning.

Cost of cancer care rising worldwide
Cancer is one of the leading causes of death and morbidity worldwide, and its economic burden grows year by year. In 2008, the worldwide cost of cancer due to premature death and disability, excluding direct medical costs, was estimated to be US$895 billion.

Novartis drug Afinitor everolimus helps advanced breast cancer women
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.

$3.5 million Komen award to study rare and aggressive type of breast cancer
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.

Alpharadin improved survival in advanced prostate cancer patients
Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong survival significantly, according to research reported recently at the 2011 European Multidisciplinary Cancer Congress.

Stress linked to breast cancer aggressiveness
Psychosocial stress could play a role in the etiology of breast cancer aggressiveness, particularly among minority populations, according to study results presented at the Fourth AACR Conference on The Science of Cancer Health Disparities, held.

Breast cancer and cervical cancer rising in developing countries
The number of cases and deaths from breast and cervical cancer are rising in most countries, especially in the developing world where more women are dying at younger ages, according to a new global analysis by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

IUDs may lower cervical cancer risk
IUDs or intrauterine contraceptive devices could substantially reduce the risk of women developing cervical cancer, revealed by researchers in a recent study in Lancet Oncology.

Mesothelioma linked to gene mutation
Individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer – mesothelioma, and melanoma of the eye. Mesothelioma tumors are typically associated with asbestos and erionite exposure.

Zelboraf approved for late stage skin cancer
The U.S. Food and Drug Administration recently approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

5 inherited genetic variants linked to prostate cancer
An international team of researchers led by Fred Hutchinson Cancer Research Center has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer.

Cigarette smoking implicated in half of bladder cancers in women
Current cigarette smokers have a higher risk of bladder cancer than previously reported, and the risk in women is now comparable to that in men, according to a study by scientists from the National Cancer Institute (NCI), part of the National Institutes of Health.

Small tumor protein oncoprotein identified in Merkel cell carcinoma
Knocking out a viral protein called "small tumor protein," or sT, stopped the cancer cells from replicating, revealed by researchers in a recent study.

New urine test can detect prostate cancer risk early
A new urine test can help aid early detection of and treatment decisions about prostate cancer. Examining the urine sample for TMPRSS2:ERG and PCA3 and stratified patient into low, intermediate and high score, indicating their risk of cancer can help.

Genetic changes may lead to Barrett's esophagus and esophageal cancer
Mutations in three genes have been identified that are more prevalent in patients with esophageal cancer and Barrett esophagus, a premalignant metaplasia (change in cells or tissue) caused by chronic gastroesophageal reflux disease (GERD), according to preliminary research reported in the July 27 issue of JAMA.

Encouraging men to seek evidence based information of prostate cancer
Encouraging men to seek up-to-date evidenced-based information from their GPs about screening and treatment of prostate cancer disease and screening for prostate cancer is recommended. The Royal New Zealand College of General Practitioners (RNZCGP) has welcomed the release of the results of the Health Select Committee's inquiry into the early detection and treatment of prostate cancer.

Therapy reduces early menopause for women with breast cancer
Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July_20 issue of JAMA.

Cancer mortality rates higher in men than women
Overall cancer mortality rates are higher for men than women in the United States. Men are more likely to die from cancer than women. For many cancers, men have poorer survival than women but the differences are slight, and this is due to the greater frequency of cancer diagnosis, rather than poorer survival once the cancer occurs.

20% reduction in lung cancer mortality with low dose CT vs chest X ray
Scientists have found a 20 percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose helical computed tomography (CT) versus those screened by chest X-ray. The primary research results from the National Lung Screening Trial (NLST) were published in the New England Journal of Medicine.

FDA panel votes to revoke approval for Avastin for advanced breast cancer
The Oncologic Drugs Advisory Committee, FDA, USA disapproved the Avastin which cited a lack of survival benefit. Now as two more trials have been analyzed -- neither showing a survival benefit -- the FDA stated that in the balance, the benefit did not outweigh the harm.

Many advanced breast cancer patients do not receive recommended treatment
Forty-five percent of women with advanced breast cancer in the U.S. did not receive postmastectomy radiation therapy (PMRT) despite the publication of evidence-based guidelines outlining PMRT as a potentially lifesaving treatment, according to new research from The University of Texas MD Anderson Cancer Center. The study, published in the July issue of Cancer, found that PMRT use rates for women with advanced breast cancer have remained static since 1999.

Shanghai Breast Health Resource Center China
The prevention, early detection and multidisciplinary treatment of breast cancer are important strategies for promoting health and extending a healthy life span. The Shanghai Breast Health Resource Center is an important step in effectively addressing breast cancer, especially to improving breast cancer screening and early detection, which are considered to be the most effective and affordable ways for a rapid reduction of breast cancer disease burden in developing countries like China.

Smoking may increase risk of prostate cancer recurrence
Researchers found that men with prostate cancer who were current smokers had a 61% increased risk of dying from prostate cancer, and a 61% higher risk of recurrence compared with men who never smoked. This new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying from the disease.

Inform Dual ISH to determine HER2 gene in breast cancer patients
Breast cancer is the second leading cause of cancer-related death among women. About 20 percent of women diagnosed with breast cancer are HER2-positive. The Inform Dual ISH test allows lab personnel to count the number of copies of HER2 genes on chromosome 17 in a small sample of the breast tumor. Copies of the HER2 gene appear black and copies of chromosome 17 appear red. Patients with more than the normal number of copies of the HER2 gene are considered candidates for Herceptin therapy.

Low carbohydrate, high protein diets may reduce cancer risk
Eating a low-carbohydrate, high-protein diet may reduce the risk of cancer and slow the growth of tumors already present, according to a study published in Cancer Research, a journal of the American Association for Cancer Research. The study was conducted in mice, but the scientists involved agree that the strong biological findings are definitive enough that an effect in humans can be considered.

Better inform consumers about sunscreen to help reduce skin cancer risk, early aging
Sunscreen products meeting modern standards for effectiveness may be labeled with new information to help consumers find products that, when used with other sun protection measures, reduce the risk of skin cancer and early skin aging, as well as help prevent sunburn. The final regulation allows sunscreen products that pass the FDA's test for protection against both ultraviolet A (UVA) and ultraviolet B (UVB) rays to be labeled as "Broad Spectrum."

Ovarian cancer screening does not improve survival
In a clinical trial that included nearly 80,000 women, those who received ovarian cancer screening did not have a reduced risk of death from ovarian cancer compared to women who received usual care, but did have an increase in invasive medical procedures and associated harms as a result of being screened.

Radiation improves survival in breast cancer surgery patients
Additional radiation treatment improves disease free survival lessening the chance of cancer recurring in women with early breast cancer who have had breast conserving surgery (lumpectomy), interim results of a new study found. The results will be presented Monday, June_6 at the annual meeting of the American Society of Clinical Oncology.

Pfizer drug reduces breast cancer in high risk women
The drug exemestane significantly reduces the risk of breast cancer in high-risk, postmenopausal women is the result of an international, randomized double-blind phase III clinical trial in which University at Buffalo researchers and hundreds of Western New York women played a critical role, revealed at the American Society of Clinical Oncology annual meeting.

Brisk walking could improve prostate cancer outcomes
Men with prostate cancer can improve their outcomes if they walk briskly for at least three hours a week following their diagnosis, according to a recent study in Cancer Research, a journal of the American Association for Cancer Research.

Coffee may reduce prostate cancer risk
It is a good news for men who regularly drink coffee. They appear to have a lower risk of developing a lethal form of prostate cancer, revealed by researchers from Harvard School of Public Health (HSPH) US.

Obese men face higher risk of prostate cancer progression
Even when treated with hormone therapy to suppress tumor growth, obese men face an elevated risk of their prostate cancer worsening, researchers at Duke University Medical Center have found.

Gene expression changes in nasal cells may help identify lung cancer
A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest - and most treatable - stages, according to a study conducted by researchers in Boston.

How breast cancer cells adapt to environmental stress
An international research team led by Dr. Tak Mak, Director, The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital (PMH), has discovered a new aspect of "metabolic transformation", the process whereby tumour cells adapt and survive under conditions that would kill normal cells.

Advanced stage prostate cancer patients experience 20 year survival rates with surgery
Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery, Mayo Clinic researchers have found. Their study found a 20-year survival rate for 80 percent of patients diagnosed with cancer that has potentially spread beyond the prostate, known as cT3 prostate cancer, and treated with radical prostatectomy, or surgery to remove the prostate gland.

Coffee may reduce breast cancer risk
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa.

Breast cancers found between mammograms more likely to be aggressive
Breast cancers that are first detectable in the interval between screening mammograms are more likely to be aggressive, fast-growing tumors according to a study published online May 3rd in the Journal of the National Cancer Institute.

Teen girls and young women need a lesson on dangers of indoor tanning
Despite repeated warnings from dermatologists on the health dangers of tanning, results of a new survey by the American Academy of Dermatology (Academy) confirmed that a large percentage of Caucasian teen girls and young women admitted using tanning beds or intentionally tanning outdoors in the past year.

A better imaging agent for heart disease and breast cancer
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography (CT) scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.

Zytiga approved for late stage prostate cancer
The U.S. Food and Drug Administration approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy).

New technique extends cancer fighting cells' potency in melanoma patients
Researchers trained white blood cells to attack tumors tend to fade away quickly when injected into cancer patients.

New class of cancer drugs could work in colon cancers with genetic mutation
A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.

Activation of biomarker may improve survival among obese patients with colorectal cancer
Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1.

Omega 3 good for heart not for prostate
The largest study ever to examine the association of dietary fats and prostate cancer risk has found what's good for the heart may not be good for the prostate.

Nanomedicine closer to reality, Stanford
A class of engineered nanoparticles -- gold-centered spheres smaller than viruses -- has been shown safe when administered by two alternative routes in a mouse study led by investigators at the Stanford University School of Medicine.

Acupuncture relieves hot flashes from prostate cancer treatment
Acupuncture provides long-lasting relief to hot flashes, heart palpitations and anxiety due to side effects of the hormone given to counteract testosterone, the hormone that induces prostate cancer, according to a study published in the April issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

Testosterone - prostate cancer link needs reevaluation
The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.

Closely monitoring better for low risk prostate cancer
A Johns Hopkins study of 769 men from across the United States recently diagnosed with low-grade prostate cancer shows that forgoing immediate surgery to remove the tumor or radiation poses no added risk of death.

Adoption of newer, more expensive prostate cancer treatments
With 180,000 men diagnosed with prostate cancer each year, it is one of the most common types of cancer in US. For this reason, it has been cited as a good marker for health care spending in general, reflective of the greater trends across the United States.

Stem cells take cues from CSF fluid in brain
Proteins in fluids bathing the brain are essential for building the brain, revealed by researchers in the journal Neuron. The finding promises to advance research related to neurological disease, cancer and stem cells.

Breast cancer survivors at higher risk for fractures
The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors, revealed by researchers in a study.

High fiber diet may lead to a healthy longer life
Dietary fiber may be associated with a reduced risk of death from cardiovascular, infectious and respiratory diseases, as well as a reduced risk of death from any cause over a nine-year period.

Gene based prostate cancer test may make more accurate treatment decisions
Researchers conducted an elaborate series of experiments to identify the genes most closely linked to the aggressive biology of prostate cancer. They found about 300 genes that distinguished the two groups - indolent versus aggressive prostate cancers.

Boost broccoli's cancer fighting power with broccoli sprouts
By overcooking their broccoli, many people destroy myrosinase – a beneficial enzyme in broccoli. Broccoli sprouts contain myrosinase in abundance. To increase the vegetable's benefits, you must sprinkle broccoli sprouts on your broccoli or make a mustard sauce to serve with broccoli.

Hormone therapy at menopause may lead to breast cancer
Hormone therapy around menopause is linked to breast cancer risk, revealed by researchers in a study published in The Journal of the National Cancer Institute.

Breast implants linked to ALCL a rare cancer
Saline and silicone gel-filled breast implants are linked to anaplastic large cell lymphoma (ALCL), a very rare type of cancer, announced by US Health Agency FDA.

Biomarker test promising for melanoma early diagnosis
Biomarker test for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma, revealed by US researchers.

Gene is mutated in 1 in 3 patients with kidney cancer
Researchers have identified a gene that is mutated in one in three patients with the most common form of renal cancer. The identification of a frequently mutated gene will provide new insights into the biology of the disease.

New drug for melanoma skin cancer patients soon
Plexxikon Inc. announced positive data from an interim analysis of the BRIM3 trial, a large multi-center Phase 3 clinical study of PLX4032 (RG7204) in patients with previously untreated metastatic melanoma with the BRAF mutation.

Follow up helps detect melanoma earlier
A follow-up program for patients at high risk of developing skin cancer appears to be associated with the detection of melanomas at early stages and with good prognosis.

New drug approach for prostate cancer drug
A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells, revealed by researchers.

Incontinence after prostate surgery reduced with behavioral therapy
For men with incontinence for at least one year following radical prostatectomy, participation in a behavioral training program that included pelvic floor muscle training, bladder control strategies and fluid management, resulted in a significant reduction in the number of incontinence episodes.

Age plays too big a role in prostate cancer treatment decisions
Older men with high-risk prostate cancer frequently are offered fewer – and less effective – choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.

Parents favor genetic testing for melanoma in their children
The vast majority of parents who tested positive for a genetic mutation that increases the risk of melanoma (the most serious form of skin cancer) support genetic testing of their children or grandchildren. Results of the two-year study at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) appear in the December issue of the journal Genetics in Medicine. The data could lead to the establishment of formal, evidence-based guidelines for genetic testing of people younger than 18 years.

Gardasil approved to prevent anal cancer
The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.

Eating healthier diet means living longer
The leading causes of death have shifted from infectious diseases to chronic diseases such as cardiovascular disease and cancer. These illnesses may be affected by diet.

Body fat distribution linked to ER negative breast cancer
Body fat distribution does not play an important role in the incidence of every subtype of premenopausal breast cancer, but is associated with an increased risk for estrogen receptor (ER)–negative breast cancer.

International clinical trial tests targeted drug for melanoma skin cancer
Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.

Celebrex may prevent some non melanoma skin cancers
New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.

Cancer news articles may contribute to confusion about cancer
New research from North Carolina State University shows that most online news stories about cancer contain language that likely contributes to public uncertainty about the disease – a significant finding, given that at least one-third of Americans seek health information online.

New risk factor for developing breast cancer
An Australian research team from the Peter MacCallum Cancer Centre, the University of Melbourne and the University of Queensland has identified a new risk factor for developing breast cancer. This has been published online in the journal Cancer Prevention Research.

Genetic test for lung cancer risk prompts smokers to quit
New research shows a gene-based test for lung cancer risk assessment motivates smokers to quit or cut down, according to results of a clinical study presented today at the American Association of Cancer Research's Ninth Annual Conference on Frontiers in Cancer Prevention Research.

Potential target identified for therapy for prostate cancer
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy.

100 Cancer articles listed above.

Subscribe to Health News by Email






What is Cancer
Cancer is not just one disease, but a large group of almost one hundred diseases. Its two main characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate from the original site and spread to distant sites. If the spread is not controlled, cancer can result in death.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.55